Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)
This grant opportunity aims to fund multi-project research focused on developing and advancing gene- and cell-based methods to achieve long-term remission or eliminate HIV. The research should cover basic scientific discovery and preclinical studies, including testing in animal models. Applicants must collaborate with at least one private sector partner.
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)
National Institutes of Health
-
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
National Institutes of Health
-
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
National Institutes of Health
-
RFA: EDS Accelerator Award
American Cancer Society
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers